Position in NVCT
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$500,208
+$452,648 QoQ
Shares Held
27,200
+369.0% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 82 holders
Holding Since
Jun 2023
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STRS OHIO holds $178,589,243 across 156 Biotechnology names. NVCT ranks #67 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
66,679 | $33,121,459 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
28,557 | $17,806,431 | |
| 3 | MRNA |
Moderna, Inc.
|
209,874 | $14,697,476 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
299,838 | $10,611,266 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
54,428 | $10,193,275 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
33,364 | $10,043,564 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
38,166 | $3,026,182 | |
| 8 | EXEL |
Exelixis, Inc.
|
52,093 | $2,834,380 |
All Filings in NVCT
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $500,208 | 27,200 | Shares | Sole | 2026-07-30 | |
| 2024-03-31 | $47,560 | 5,800 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $51,708 | 6,200 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $50,271 | 3,900 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $22,358 | 1,400 | Shares | Sole | 2023-07-31 | |
| No filing history on record for this holder in this stock. | ||||||